---
title: "New China Life Insurance Forecasts 40%–60% Surge in First-Half 2026 Profit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292476810.md"
description: "New China Life Insurance forecasts a 40%-60% year-on-year surge in first-half 2026 net profit, estimated at RMB20.7 billion to RMB23.7 billion. The growth is attributed to high-quality development strategies, core business focus, and robust investment returns. While the company cites no significant uncertainties, it warns of trading risks before official results are released. Analysts currently maintain a 'Sell' rating with a HK$33.00 price target."
datetime: "2026-07-13T10:38:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292476810.md)
  - [en](https://longbridge.com/en/news/292476810.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292476810.md)
generator: "portal-rs"
---

# New China Life Insurance Forecasts 40%–60% Surge in First-Half 2026 Profit

New China Life Insurance Co., Ltd. Class H ( (HK:1336) ) has issued an announcement.

New China Life Insurance Company Ltd. expects a sharp increase in interim profits for the first half of 2026, with net profit attributable to shareholders projected at approximately RMB20.7 billion to RMB23.7 billion, up 40% to 60% year on year. Excluding non-recurring items, profit is forecast at roughly the same range, underscoring strong underlying earnings momentum.

Management attributes the profit surge to its focus on high-quality, inward-looking development and a stronger emphasis on its core life insurance business. The insurer has deepened market-oriented reforms, advanced an integrated “insurance + service + investment” model, invested in AI-enabled services, and optimized asset allocation to support national strategic sectors, which together have boosted competitiveness and delivered robust investment returns.

The company says there are no significant uncertainties that could materially affect these estimates, though the figures remain unaudited pending the publication of its 2026 interim report. It cautions investors to be mindful of risks when trading its shares until the full results are disclosed.

The most recent analyst rating on (HK:1336) stock is a Sell  
 with a HK$33.00 price target.  
 To see the full list of analyst forecasts on New China Life Insurance Co., Ltd. Class H stock,  
 see the HK:1336 Stock Forecast page. 

**More about New China Life Insurance Co., Ltd. Class H**

New China Life Insurance Company Ltd. is a major Chinese life insurer, focusing on core life insurance products and related protection services. The company is expanding a customer-centric ecosystem that combines insurance with services such as medical care, healthcare, and elderly care, while also enhancing its investment operations across China’s capital markets.

**Average Trading Volume:** 9,177,114

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$198.8B

### Related Stocks

- [601336.CN](https://longbridge.com/en/quote/601336.CN.md)
- [01336.HK](https://longbridge.com/en/quote/01336.HK.md)

## Related News & Research

- [M Stanley Raises NCI  TP to HKD39.9, Rated Underweight](https://longbridge.com/en/news/298991169.md)
- [New China Life files board, board committee member list with disclosure duties](https://longbridge.com/en/news/297289425.md)
- [AIA: Record traffic and resilient profits drive a flexible, phased €950M expansion through 2030](https://longbridge.com/en/news/298619263.md)
- [J.P. Morgan Sticks to Their Hold Rating for New China Life Insurance Co., Ltd. Class H (1336)](https://longbridge.com/en/news/294762808.md)
- [Prudential Financial announces R$ 2.41 per unit dividend for Q3 2026 BDRs](https://longbridge.com/en/news/298940810.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**